Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Prophylactic Vancomycin on Bloodstream Infections After ECMO Liberation
NCT05651464Unknown
- Sponsor
- Saarland University
- Start
- Jan 2023
- Primary completion
- Dec 2023
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of vancomycin in catheter infection (2 arms), sponsored by Saarland University. Primary endpoint: Growth of pathogens in blood culture. Status: unknown.
02
Drugs
vancomycin
03
Conditions
catheter infection
Beyond the preview
Go deeper on NCT05651464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05651464.